Advanced Design, Development, and Delivery of Skin-Mediated Therapies and Vaccines
The growing interest in alternative routes of drug administration has experts predicting that the market for transdermal and intradermal drug delivery systems will exceed $25 billion by 2018. The industry is on the threshold of bringing into commercial production a new generation of transformative TDD and IDD therapies and delivery systems. That is why you cannot afford to miss this two-day intensive conference. Pharma Ed brings together leading researchers in the field to share the most recent advances in the design, formulation, and delivery of skin-mediated therapies and vaccines.
Featuring Representation From:
- Pfizer
- Merck
- Corium
- 3M
- MIT
- UCSB
- Queens University, Belfast
- Georgia Tech
- Texas Tech
- University of Mississippi
- University of Cincinnati
- Mercer University
- University of Maryland
- QPS
- Intertek
- Eurofins Lancaster Labs
- ISYN Consulting
- Zosano Pharma
With Comprehensive Coverage on:
- Improving Bioavailability Via Transdermal Administration
- Latest Advances in Microneedle Drug and Vaccine Delivery
- How to Move from Passive to Active Skin-Mediated Delivery Technologies for Drugs and Biologics
- Optimizing TDD & IDD for Efficacious Delivery and Patient Compliance
- Mechanisms of Dermal and Transdermal Absorption of Drugs
- Computational Modeling of Transdermal and Intradermal Delivery
- Resolving Regulatory Compliance Issues for TDD & IDD Systems
- IVPT and IVRT of Transdermal and Topical Products
- Exploring the Promise of Ionic Liquids for Transdermal Applications
- And much more!
Reviews
There are no reviews yet.